WCG Buys E-clinical Software and Translation Provider VeraSci
US-based clinical research provider WCG acquires VeraSci, a provider of e-clinical software and translation, for USD 330m; plans Nasdaq IPO.
US-based clinical research provider WCG acquires VeraSci, a provider of e-clinical software and translation, for USD 330m; plans Nasdaq IPO.
Where is demand for language services and technology heading in 2016, and what should providers know about the trends affecting buyers? Download Slator's 2015/16 Demand Driver report.
CROs have become some of the language industry’s most coveted and profitable clients with accounts potentially exceeding 5mn USD or more in annual billings.
As CROs are increasingly relying on ePRO in clinical trials, the demand for translation and localization of ePRO systems may likewise increase.
Your information will never be shared with third parties. No Spam.